Lippincott ^® NursingCenter ^®

Departments

• Free

  3 Questions on...Improving Cancer Survival Disparities in Minority Populations: With Abiola Ibraheem, MD, of University of Chicago Medicine

  Sarah DiGiulio

• Free

  Breakthrough Therapy Designation for Avelumab Use in RCC
• Free

  Brigatinib (Alunbrig®)

  Janelle E. Mann PharmD, BCOP

• Free

  Cabozantinib Approved for Untreated Renal Cell Carcinoma
• Free

  Cancer Researchers Hit a Bullseye With New Drug Target for Ewing Sarcoma
• Free

  Daratumumab Granted Priority Review for Multiple Myeloma
• Free

  EZH2 Inhibitor Shows Promise Among Children With Certain Solid Tumors

  Catlin Nalley

• Free

  Frontline Brentuximab Plus Standard Therapy Improves Hodgkin Lymphoma

  Mark L. Fuerst

• Free

  Gene-Modified, Virus-Specific T-Cell Therapy for Lymphoma
• Free

  High Body Fat Levels Associated With Increased Breast Cancer Risk
• Free

  Innovative Combination Extends PFS to 8 Months in Metastatic Colorectal Cancer

  Mark L. Fuerst

• Free

  Liquid Biopsy Test Shows Promise in Early-Stage Colorectal Cancer

  Mark L. Fuerst

• Free

  Making Milestones Against Non-Small Cell Lung Cancer
• Free

  More Evidence of Link Between Severe Gum Disease & Cancer Risk
• Free

  New Indication Approved for Afatinib in NSCLC
• Free

  New Treatment for Certain Digestive Tract Cancers
• Free

  Obese Men May Have Higher Cancer Recurrence After Prostatectomy
• Free

  On Harvey & Hematology

  Naveen Pemmaraju MD

• Free

  Oral Anticoagulant Edoxaban Alternative for Cancer-Related Thromboembolism

  Peter M. Goodwin

• Free

  Preventing Skeletal-Related Events in Multiple Myeloma
• Free

  Researchers Identify New Treatment Target for Melanoma
• Free

  Rise in Canadian Obesity Rate May Lead to Higher Cancer Burden
• Free

  Study Suggests PD-1 Inhibitors Against Aggressive Pediatric Brain Cancer
• Free

  Subcutaneous Daratumumab Potential Game Changer for Multiple Myeloma

  Peter M. Goodwin

• Free

  Treatment for Metastatic Breast Cancer With BRCA-Mutation
• Free

  UpToDate®
• Free

  Venetoclax Pro-Apoptotic Therapy Benefits Older Patients With AML

  Peter M. Goodwin

• Free

  Who's Still Smoking: Report Highlights Populations Still at Risk
• Buy

  Non-Hormonal Therapy for Recurrent Non-Metastatic Prostate Cancer

  Avi Retter MD

• Buy

  PI3K Inhibition in Relapsed/Refractory Indolent Non-Hodgkin Lymphoma

  Martin Dreyling MD, PhD

• Buy

  Post-Resection Stereotactic Radiosurgery in the Treatment of Brain Metastases

  Paul Brown MD

• Buy

  Shop Talk
• Buy

  Therapeutic Options for Relapsed/Refractory Mantle Cell Lymphoma

  Pamela Crilley DO